Back to Agenda
Session 5, Part 1: Tech Innovation for Life Sciences
Session Chair(s)
Scott Askin, MSc
Global Program Regulatory Director, Novartis Pharma AG, Switzerland
Michael Von Forstner, PhD, MPH, MSc
Chief Science Officer, MedGenie AG, Switzerland
Session 5, Part 1: Tech Innovation for Life Sciences
Speaker(s)
AI Application for Early Diagnosis in Rare Disease
Greg Davis
COO, Analytics4Life (A4L), United States
Have an account?